Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240

Oncology Reports

Volumn 30, Issue 3, 2013, Pages 1035-1044

  Ghrici, Mohamed ^a   El Zowalaty, Mohamed ^b   Omar, Abdul Rahman ^a,b   Ideris, Aini ^b  

^a Departments of Veterinary Pathology and Microbiology   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Apoptosis; Hemagglutinin neuraminidase glycoprotein; MCF 7; Newcastle disease virus AF2240

Indexed keywords

HN PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG BINDING; DRUG CYTOTOXICITY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSFECTION; HN GENE; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEWCASTLE DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CHICK EMBRYO; CHICKENS; FEMALE; FLOW CYTOMETRY; HN PROTEIN; HUMANS; IMMUNOENZYME TECHNIQUES; MCF-7 CELLS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIROTHERAPY; PLASMIDS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84880590344     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2573     Document Type: Article

References (68)

1. International Committee on Taxonomy of Viruses (ICTV): http://ictvonline.org/taxonomyHistory.asp?taxnode-id=20114200&taxa-name= Newcastle%20disease%20virus. 2012.
2. Choppin PW and Compans RW: Reproduction of Paramyxoviruses. In: Comprehensive Virology. Fraenkel-Conrat H and Wagner RR (eds). Vol 4. Plenum Press, New York, pp95-178, 1975.
3. Stone-Hulslander J and Morrison TG: Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol 71: 6287-6295, 1997.
4. Steward M, Vipond IB, Millar NS and Emmerson PT: RNA editing in Newcastle disease virus. J Gen Virol 74: 2539-2547, 1993.
5. Alexander DJ: Newcastle disease. Br Poult Sci 42: 5-22, 2001.
6. Kumar R, Tiwari AK, Chaturvedi U, et al: Velogenic Newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization: Appl Biochem Biotechnol 167: 2005-2022, 2012
7. Sinkovics JG and Horvath JC: Newcastle disease virus (NDV): brief history of its oncolytic strains. J Clin Virol 16: 1-15, 2000.
8. Lai MC and Ibrahim AL: Velogenic viscerotropic Newcastle disease virus. In: Newcastle Disease in Poultry: a new food pellet vaccine. Copland JW (ed). Vol monograph 5. ACIAR, Canberra, pp33-34, 1987.
9. Millar NS, Chambers P and Emmerson PT: Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus. J Gen Virol 67: 1917-1927, 1986.
10. Huang Z, Panda A, Elankumaran S, Govindarajan D, Rockemann DD and Samal SK: The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol 78: 4176-4184, 2004.
11. Choppin PW and Scheid A: The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis 2: 40-61, 1980.
12. Schirrmacher V, Haas C, Bonifer R, Ahlert T, Gerhards R and Ertel C: Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Gene Ther 6: 63-73, 1999.
13. Fábián Z, Csatary CM, Szeberényi J and Csatary LK: p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines. J Virol 81: 2817-2830, 2007.
14. Reichard KW, Lorence RM, Cascino CJ, et al: Newcastle disease virus selectively kills human tumor cells. J Surg Res 52: 448-453, 1992.
15. Schirrmacher V and Fournier P: Newcastle disease virus: a promising vector therapy of cancer. In: Viral Therapy of Cancer. Kevin JH, Richard GV and Hardev SP (eds): Wiley, New Jersey, pp171-186, 2008.
16. Elankumaran S, Rockemann D and Samal SK: Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80: 7522-7534, 2006.
17. Washburn B, Weigand MA, Grosse-Wilde A, et al: TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus. J Immunol 170: 1814-1821, 2003.
18. Lorence RM, Rood PA and Kelley KW: Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-α and augmentation of its cytotoxicity. J Natl Cancer Inst 80: 1305-1312, 1988.
19. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690, 1996.
20. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999.
21. Sun Y, Jin N, Mi Z, Li X, Lian H and Li P: Induction of apoptosis in human hepatoma cell line SMMC7721 by Newcastle disease virus HN gene. Zhonghua Zhong Liu Za Zhi 27: 279-282, 2005 (In Chinese).
22. Zeng J, Fournier P and Schirrmacher V: Induction of interferon-α and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virus. Virology 297: 19-30, 2002.
23. Schirrmacher V, Haas C, Bonifer R and Ertel C: Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection. Clin Cancer Res 3: 1135-1148, 1997.
24. Sui H, Bai Y, Wang K, et al: The anti-tumor effect of Newcastle disease virus HN protein is influenced by differential subcellular targeting. Cancer Immunol Immunother 59: 989-999, 2010.
25. Ni J, Galani IE, Cerwenka A, Schirrmacher V and Fournier P: Antitumor vaccination by Newcastle disease virus hemagglutinin-neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity. Vaccine 29: 1185-1193, 2011.
26. Ravindra P, Tiwari AK, Sharma B, et al: HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells. Arch Virol 153: 749-754, 2008.
27. Alabsi AM, Bakar SAA, Ali R, et al: Effects of Newcastle disease virus strains AF2240 and V4-UPM on cytolysis and apoptosis of leukemia cell lines. Int J Mol Sci 12: 8645-8660, 2011.
28. Ali R, Alabsi AM, Ali AM, et al: Cytolytic effects and apoptosis induction of Newcastle disease virus strain AF2240 on anaplastic astrocytoma brain tumor cell line. Neurochem Res 36: 2051-2062, 2011.
29. Molouki A and Yusoff K: NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria. Virol J 9: 179, 2012.
30. Bakar SAA, Zawawi M, Ali AM and Ideris A: Induction of apoptosis by Newcastle disease virus strains AF220 and V4-UPM in human promyelocytic leukemia (HL60) and human T-lymphoblastic leukemia (CEM-SS) cells. World Acad Sci Eng Technol 64: 395-399, 2012.
31. Molouki A, Hsu YT, Jahanshiri F, Rosli R and Yusoff K: Newcastle disease virus infection promotes Bax redistribution to mitochondria and cell death in HeLa cells. Intervirology 53: 87-94, 2010.
32. Yusoff K, Tan WS, Lau CH, Ng BK and Ibrahim AL: Sequence of the haemagglutinin-neuraminidase gene of the Newcastle disease virus oral vaccine strain V4(UPM). Avian Pathol 25: 837-844, 1996.
33. Nicoletti I, Migliorati G, Pagliacci M, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
34. Hale AJ, Smith CA, Sutherland LC, et al: Apoptosis: molecular regulation of cell death. Eur J Biochem 236: 1-26, 1996.
35. Elmore S: Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
36. O'Brien V: Viruses and apoptosis. J Gen Virol 79: 1833-1845, 1998.
37. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786-789, 1993.
38. Cohen JJ, Duke RC, Fadok VA and Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10: 267-293, 1992.
39. Csatary LK and Bakács T: Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma. JAMA 281: 1588-1589, 1999.
40. Freeman AI, Zakay-Rones Z, Gomori JM, et al: Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. Mol Ther 13: 221-228, 2006.
41. Karcher J, Dyckhoff G, Beckhove P, et al: Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res 64: 8057-8061, 2004.
42. Pecora AL, Rizvi N, Cohen GI, et al: Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J Clin Oncol 20: 2251-2266, 2002.
43. Schirrmacher V: Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory. Cancer Immunol Immunother 54: 587-598, 2005.
44. Steiner HH, Bonsanto MM, Beckhove P, et al: Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit. J Clin Oncol 22: 4272-4281, 2004.
45. Zhou J, Law HKW, Cheung CY, Ng IHY, Peiris JSM and Lau YL: Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophages. J Infect Dis 193: 945-953, 2006.
46. Clarke P, Meintzer SM, Gibson S, et al: Reovirus-induced apoptosis is mediated by TRAIL. J Virol 74: 8135-8139, 2000.
47. Vidalain PO, Azocar O, Lamouille B, Astier A, Rabourdin-Combe C and Servet-Delprat C: Measles virus induces functional TRAIL production by human dendritic cells. J Virol 74: 556-559, 2000.
48. Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL and Bukreyev A: Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 77: 9156-9172, 2003.
49. Collins PL and Hightower LE: Newcastle disease virus stimulates the cellular accumulation of stress (heat shock) mRNAs and proteins. J Virol 44: 703-707, 1982.
50. Sunila I, Vaccarezza M, Pantaleo G, Fauci AS and Orenstein JM: gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV-1-infected individuals: an immunoelectron microscopic study. AIDS 11: 27-32, 1997.
51. Connolly JL, Barton ES and Dermody TS: Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol 75: 4029-4039, 2001.
52. Fournier P, Zeng J and Schirrmacher V: Two ways to induce innate immune responses in human PBMCs: Paracrine stimulation of IFN-α responses by viral protein or dsRNA. Int J Oncol 23: 673-680, 2003.
53. Washburn B and Schirrmacher V: Human tumor cell infection by Newcastle disease virus leads to upregulation of HLA and cell adhesion molecules and to induction of interferons, chemokines and finally apoptosis. Int J Oncol 21: 85-93, 2002.
54. Szeberényi J, Fábián Z, Töröcsik B, Kiss K and Csatary LK: Newcastle disease virus-induced apoptosis in PC12 pheochromocytoma cells. Am J Ther 10: 282-288, 2003.
55. Molouki A, Hsu YT, Jahanshiri F, Abdullah S, Rosli R and Yusoff K: The matrix (M) protein of Newcastle disease virus binds to human bax through its BH3 domain. Virol J 8: 385, 2011.
56. Préhaud C, Lay S, Dietzschold B and Lafon M: Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. J Virol 77: 10537-10547, 2003.
57. Tan W, Lau C, Ng B, Ibrahim A and Yusoff K: Nucleotide sequence of the haemagglutinin-neuraminidase (HN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240. DNA Seq 6: 47-50, 1995.
58. Mymryk J, Shire K and Bayley S: Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene 9: 1187-1193, 1994.
59. Joe AK, Foo HH, Kleeman L and Levine B: The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death. J Virol 72: 3935-3943, 1998.
60. Yao Q, Compans RW and Chen C: HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Virology 285: 128-137, 2001.
61. Wang K, Sui H, Li L, Li X and Wang L: Anti-tumor immunity of Newcastle disease virus HN protein is influenced by differential subcellular targeting. Zhongguo Fei Ai Za Zhi 13: 773-776, 2010 (In Chinese).
62. Castedo M, Roumier T, Blanco J, et al: Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J 21: 4070-4080, 2002.
63. Lam KM, Kabbur MB and Eiserich JP: Newcastle disease virus-induced functional impairments and biochemical changes in chicken heterophils. Vet Immunol Immunopathol 53: 313-327, 1996.
64. Kommers GD, King DJ, Seal BS and Brown CC: Pathogenesis of chicken-passaged Newcastle disease viruses isolated from chickens and wild and exotic birds. Avian Dis 47: 319-329, 2003.
65. Ravindra P, Tiwari AK, Ratta B, Chaturvedi U, Palia SK and Chauhan R: Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis. Virus Res 141: 13-20, 2009.
66. Vigil A, Park MS, Martinez O, et al: Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 67: 8285-8292, 2007.
67. Bian H, Fournier P, Moormann R, Peeters B and Schirrmacher V: Selective gene transfer to tumor cells by recombinant Newcastle disease virus via a bispecific fusion protein. Int J Oncol 26: 431-439, 2005.
68. Ertel C, Millar NS, Emmerson PT, Schirrmacher V and Von Hoegen P: Viral hemagglutinin augments peptide-specific cytotoxic T cell responses. Eur J Immunol 23: 2592-2596, 1993.